MPA Business Services · since 1973
Pharmaceutical patent, SPC,
pricing and licensing intelligence
Search patent expiries, exclusivity dates, licences and medicine prices in one place, with specialist help to interpret the results.
Existing client? Log in.
What MPA helps you decide
Is your product’s loss of exclusivity approaching? Check the position of any product before you source, launch, license or litigate.
When exclusivity ends
Patent, supplementary protection certificate (SPC) and paediatric extension expiries, country by country, so you know when generic entry becomes possible and how long a branded parallel import opportunity lasts.
Assess sourcing and launch opportunities
Licences, holders and first EU marketing authorisation dates, the basis of data and marketing exclusivity, checked against the official registers.
Compare published list prices
Published national list prices across European markets, at presentation level, for sourcing and pricing decisions.
The dates that matter
Understand the dates behind loss of exclusivity
Patent expiry is one part of the picture. A supplementary protection certificate, a paediatric extension and regulatory data and marketing exclusivity may also affect the assessment, and each is granted or calculated nationally, so the position can differ by country.
The diagram is a simplified example, not the position for any particular product. MPA Search holds each of these dates for each country, with the reference that lets you check the original record.
The datasets behind itHow it works
Search, review, interpret
MPA Search is a subscription web application: every dataset your company subscribes to behind one search, online, with nothing to install. Access is by named user, with datasets and countries set for your company.
- 1
Search
A substance, product, company or reference number, or a whole list of products pasted in at once.
- 2
Review
Results from each dataset side by side, with the dates, countries and source references you need.
- 3
Interpret
Unsure what a result means for your enquiry? Ask. Help with interpretation is part of every subscription.
What it covers
Six datasets, one search
Each built from the official register or publication.
Patents & SPCs
Major product patents, SPCs and paediatric extensions for products on the European market.
Patent and SPC registers
EU first marketing authorisations
The dates that exclusivity periods run from.
EMA and the Union Register
Product licences
National marketing authorisations across the UK and Europe.
National licensing authorities
Parallel import licences
Licences and importers under national parallel importation schemes.
National licensing authorities
Prices
Published national list prices, market by market.
National price lists
NHS prescribing data
Volumes, items and list-price value for every medicine prescribed in the community and used in hospitals in England, with trends and shares.
NHSBSA prescribing and hospital medicines data
Patent & SPC coverage
32 countries
Every EU member state plus the UK, Switzerland, Norway, Iceland and Liechtenstein, searchable one country at a time or by preset, such as the Big 6 markets.
Why rely on it
Since
1973
Pharmaceutical data and intelligence for small generics and pharma companies, pan-global industry players, trade associations and government bodies.
About MPA- companies and organisations served
- 250+
- companies and organisations served
- countries for patents and SPCs
- 32
- countries for patents and SPCs
- datasets behind one search
- 6
- datasets behind one search
Traceable to the source
MPA takes the official sources: national and European patent and SPC registers, the national licensing authorities, European Medicines Agency publications and first-authorisation records. Every record keeps its reference number, so it can be traced back to the register it came from.
What is included
With every subscription
- Help understanding the data supplied
- Its relevance to your enquiry
- At no extra charge
Commissioned separately
- Patent and product evaluations
- Market intelligence
- Other research beyond the subscribed data
Clients
Who uses MPA Search
Generics and originator companies
Expiry and exclusivity positions for launch planning and lifecycle decisions.
Parallel traders and wholesalers
Licences, importers and the patent position of the products they import.
Patent lawyers and licensing teams
Authorisations, holders and dates checked against the official records.
Trade associations and public bodies
Reference data and analysis for policy and procurement work.
“Having used MPA over many years it has formed a key part of our business planning process. The data provided allows my team to make product identification clearly targeted.”
“An invaluable component of our marketing and corporate decision-making strategic planning processes.”
“We have always found the service offered to be helpful and efficient.”
From Resources
Plain answers on patents, exclusivity and prices
Case notes, explainers and guides written for the people who source, launch and buy medicines, each sourced to the register or judgment behind it.
Latest regulatory change
The EU's new data and market exclusivity rules: eight plus one, extensions to earn, and who they apply to
The agreed EU pharmaceutical package keeps eight years of data protection but cuts baseline market protection from two years to one, with one-year extensions that have to be earned and an eleven-year cap. Adopted by the Council in September 2026, awaiting Parliament's vote, and applying only to products filed from late 2028. What changes, what does not, and what it means for generic entry dates.
24 October 2026 · 6 min read
- ExplainersOne product, five clocksPatent expiry, SPC expiry, paediatric extension, data exclusivity and market protection are five separate clocks on one product. They start from different events, run under different laws, and the last one to stop sets the real loss-of-exclusivity date. A one-page map, with a checklist.
- PricesHow medicine list prices are published across EuropeThere is no European price list. Each country publishes its own, in its own format, showing a different point on the price ladder, on a different schedule, and some publish nothing free at all. A country-by-country map of the official sources, written for people comparing prices across borders.
- GlossaryWhat the fields in a patent or SPC record meanA patent register entry is a dozen dates and codes, and only two of them decide when a product opens up. Each field defined plainly, with what it is used for commercially, the status words that mean the right has gone, and the SPC fields that sit alongside.
See MPA Search in action
A free online demonstration with our team.
- Free
- Online
- With our team